Revvity Unveils a New Era of Automated Tuberculosis Testing
![Business Wire](../../../Content/images/providers/BW.png)
Revvity, Inc. (RVTY)
Company Research
Source: Business Wire
New and improved workflow now available that pairs Revvity’s T-SPOT™.TB test with the Auto-Pure 2400 liquid handling platformSubstantially lowers hands-on time, allowing for increased lab productivity WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform is easy to use and designed to provide efficient workflows in the lab. When the accuracy of the T-SPOT.TB test is combined with the efficiency of the Auto-Pure 2400 system, labs, clinicians and ultimately patients, benefit from the resultant powerful solution.“The ability to use the Auto-Pure 2400 platform with our T-SPOT.TB test provides labs an efficient workflow allowing latent TB testing to be run in a mid-high-volume setting, without having to compromise on the clinical performance of the test,” said Darren Sher, general manager, infectious diseases for Revvity. “With this solution, m
Show less
Read more
Impact Snapshot
Event Time:
RVTY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RVTY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVTY alerts
High impacting Revvity, Inc. news events
Weekly update
A roundup of the hottest topics
RVTY
News
- Revvity, Inc. (NYSE: RVTY) had its price target lowered by analysts at Barclays PLC from $116.00 to $115.00. They now have an "equal weight" rating on the stock.MarketBeat
- Revvity, Inc. (NYSE: RVTY) is now covered by analysts at Jefferies Financial Group Inc.. They set a "hold" rating and a $115.00 price target on the stock.MarketBeat
- Revvity to Present at Goldman Sachs Global Healthcare ConferenceBusiness Wire
- Revvity, Inc. (NYSE: RVTY) had its price target raised by analysts at Robert W. Baird from $126.00 to $127.00. They now have an "outperform" rating on the stock.MarketBeat
- Revvity, Inc. (NYSE: RVTY) had its price target raised by analysts at TD Cowen from $123.00 to $130.00. They now have a "buy" rating on the stock.MarketBeat